PUS4_TRUB1 inhibitors are a class of chemical compounds that focus on the inhibition of a specific enzyme known as Pseudouridine Synthase 4 (PUS4) in the species Trichomonas brucei (denoted as TRUB1). Pseudouridine synthases are enzymes that catalyze the isomerization of uridine to pseudouridine in RNA molecules. Pseudouridylation is a post-transcriptional modification that alters the stability and function of RNA, including tRNA and rRNA, by enhancing the molecules' structural rigidity and contributing to the fidelity of protein synthesis. The PUS4 enzyme, in particular, plays a vital role in the biogenesis of RNA by modifying specific uridine residues, which are critical for maintaining the proper structure and function of RNA. Inhibitors targeting PUS4_TRUB1 are designed to bind to this enzyme and block its activity, thereby affecting the modification process of RNA molecules within the organism.
The design and development of these inhibitors are rooted in the understanding of the enzyme's structure and the biochemistry of the pseudouridylation process. By interfering with PUS4_TRUB1 activity, these inhibitors are able to modulate the RNA maturation process, with a variety of downstream effects on cellular functions. The inhibitors must have high specificity for the PUS4 enzyme to ensure that they do not inadvertently affect similar enzymes in off-target species. The specificity is achieved through the careful design of the inhibitors' molecular structures, which often involves mimicking the natural substrates of the enzyme or binding to unique active site residues. The chemical composition of PUS4_TRUB1 inhibitors typically includes moieties that allow for the tight and specific binding to the enzyme, with the aim of maximizing the inhibition while reducing non-specific interactions. Research in this domain focuses on elucidating the precise mechanisms by which these inhibitors affect the enzyme's activity and how they interact with the enzyme's active site, often using techniques such as X-ray crystallography, computational modeling, and biochemical assays.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lapatinib | 231277-92-2 | sc-353658 | 100 mg | $412.00 | 32 | |
Lapatinib inhibits both EGFR and HER2/neu tyrosine kinases, potentially affecting PUS4_TRUB1 activity if it is involved in pathways regulated by these receptors. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $56.00 $260.00 $416.00 | 129 | |
Sorafenib is a multikinase inhibitor that targets RAF kinases, VEGFR, and PDGFR. Inhibition of these kinases might decrease PUS4_TRUB1 activity if it is involved in pathways regulated by these receptors. | ||||||